News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Bristol-Myers Squibb Company To Pay $300 Million In Settlement
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Drug giant Bristol-Myers Squibb Co. said Friday it will pay $300 million to settle a class-action lawsuit that accused the company of lying about accounting and its investment in ImClone Systems Inc.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Bristol Myers Squibb Company
MORE ON THIS TOPIC
Policy
Germany rethinking drug price reforms after Lilly, Boehringer withdraw investments:
Reuters
June 15, 2026
·
2 min read
·
Nick Paul Taylor
Psychedelics
Despite FDA trial clearance, ibogaine metabolite won’t receive red carpet treatment
June 15, 2026
·
10 min read
·
Gabrielle Masson
Opinion
The next FDA commissioner must be a champion for gene therapies
June 5, 2026
·
4 min read
·
Erik Paulsen
Policy
FDA taps prior knowledge to expedite cell and gene therapy development
June 3, 2026
·
12 min read
·
BioSpace Editorial Staff
